<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="with lopinavir/ritonavir (Chan et al., 2015; Sheahan et al., 2020)," exact="ribavirin" post="(Chen et al., 2004; Morgenstern et al., 2005; Omrani"/>
 <result pre="(Sheahan et al., 2020), while a combination of IFNÎ±2a with" exact="ribavirin" post="delayed mortality without decreasing it on the long run"/>
 <result pre="(Omrani et al., 2014). Similarly, the combination of IFNÎ±2b with" exact="ribavirin" post="gave excellent results in the rhesus macaque (Falzarano et"/>
 <result pre="in pulmonary endothelial cells, resulting in the secretion of anti-inflammatory" exact="adenosine" post="and the maintenance of endothelial barrier function. This process"/>
 <result pre="inhalation twice a day to the patients, in combination with" exact="ribavirin" post="(Dong et al., 2020; Lu, 2020). Clinical trials have"/>
 <result pre="lopinavir/ritonavir and IFNÎ±2b (ChiCTR2000029387) or a combination of lopinavir/ritonavir with" exact="ribavirin" post="and IFNÎ²1b administered subcutanously (NCT04276688) for the treatment of"/>
 <result pre="(Mager and Jusko, 2002). The combination of IFN-I with lopinavir/ritonavir," exact="ribavirin" post="or remdesivir could improve its efficacy, because of the"/>
 <result pre="syndrome coronavirus: an observational studyInt. J. Infect. Dis.202014424610.1016/j.ijid.2013.12.00324406736 ArabiY.M.ShalhoubS.Al-OmariA.MandourahY.Al-HameedF.SindiA.AlraddadiB.Al-MotairiA.Al-KhatibK.Abdul-MomminA.QushmaqI.A.MadyA.SolaimanO.Al-AithanA.BalkhyH.H.Al-RaddadiR.RajabA.Al-MekhlafiG.A.Al-HarthyA.KharabaA.Al-JabbaryA.PintoR.SadatM.Al-MutairiH.Al-QasimE.JoseJ.DeebA.M.MersonL.HaydenF.G.FowlerR.AldawoodA.S.Effect of" exact="ribavirin" post="and interferon on the outcome of critically ill patients"/>
 <result pre="prevent acute viral respiratory infections in military recruitsVaccine2820104445445110.1016/j.vaccine.2010.03.06220394720 HartB.J.DyallJ.PostnikovaE.ZhouH.KindrachukJ.JohnsonR.F.OlingerG.G.FriemanM.B.HolbrookM.R.JahrlingP.B.HensleyL.Interferon-Î² and" exact="mycophenolic acid" post="are potent inhibitors of middle east respiratory syndrome coronavirus"/>
 <result pre="host defensesAnnu. Rev. Immunol.32201451354510.1146/annurev-immunol-032713-12023124555472 ShalhoubS.FarahatF.Al-JiffriA.SimhairiR.ShammaO.SiddiqiN.MushtaqA.IFN-Î±2a or IFN-Î²1a in combination with" exact="ribavirin" post="to treat Middle East respiratory syndrome coronavirus pneumonia: a"/>
</results>
